Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

No Sales Model Left Behind: Novartis Joins Firms In Changing Market Focus

Executive Summary

Novartis is joining the horde of pharmaceutical companies that are revamping their sales and marketing organizations in response to a U.S. market that is rapidly changing, at varying paces in different regions
Advertisement

Related Content

Novartis Revamps U.S. Pharma Unit, With New CEO Andre Wyss
Pharmaceutical/Biotechnology Deal Statistics Quarterly, Q2 2009
The Heart Of A Pipeline: Can Novartis Keep The Cardio Portfolio Beating?
Nektar Continues To Refocus With Sale Of Pulmonary Business To Novartis
Merck Commercial Model: Expand Customer Base, Tighten Marketing Spend
Sandoz Branding Itself As Generics Shop With Hard-To-Manufacture Products
Waking the Giant: Business Model Innovation in the Drug Industry
Novartis First Quarter Sales Bolstered By Gleevec, Diovan
Novartis Cuts 2,500 More Jobs In Drive To Save $1.6 Billion By 2010
Novartis Cuts 2,500 More Jobs In Drive To Save $1.6 Billion By 2010
Advertisement
UsernamePublicRestriction

Register

PS050272

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel